These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. Senkovich O; Schormann N; Chattopadhyay D Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691 [TBL] [Abstract][Full Text] [Related]
5. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities. Monaghan P; Bell A Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653 [TBL] [Abstract][Full Text] [Related]
6. Identification of the optimal third generation antifolate against P. falciparum and P. vivax. Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688 [TBL] [Abstract][Full Text] [Related]
7. Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions. Verkhivker GM; Rejto PA; Bouzida D; Arthurs S; Colson AB; Freer ST; Gehlhaar DK; Larson V; Luty BA; Marrone T; Rose PW J Mol Recognit; 1999; 12(6):371-89. PubMed ID: 10611647 [TBL] [Abstract][Full Text] [Related]
8. Cyclophilin-promoted folding of mouse dihydrofolate reductase does not include the slow conversion of the late-folding intermediate to the active enzyme. von Ahsen O; Lim JH; Caspers P; Martin F; Schönfeld HJ; Rassow J; Pfanner N J Mol Biol; 2000 Mar; 297(3):809-18. PubMed ID: 10731431 [TBL] [Abstract][Full Text] [Related]
9. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols. Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255 [TBL] [Abstract][Full Text] [Related]
10. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors. Nirmalan N; Sims PF; Hyde JE Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068 [TBL] [Abstract][Full Text] [Related]
11. Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. Sirichaiwat C; Intaraudom C; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y J Med Chem; 2004 Jan; 47(2):345-54. PubMed ID: 14711307 [TBL] [Abstract][Full Text] [Related]
12. Characterization of dihydrofolate reductases from multiple strains of Plasmodium falciparum using mathematical descriptors of their inhibitors. Basak SC; Mills D; Hawkins DM Chem Biodivers; 2011 Mar; 8(3):440-53. PubMed ID: 21404427 [TBL] [Abstract][Full Text] [Related]
13. Stoichiometric selection of tight-binding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase. Kamchonwongpaisan S; Vanichtanankul J; Tarnchompoo B; Yuvaniyama J; Taweechai S; Yuthavong Y Anal Chem; 2005 Mar; 77(5):1222-7. PubMed ID: 15732900 [TBL] [Abstract][Full Text] [Related]
15. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase. Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname. Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289 [TBL] [Abstract][Full Text] [Related]
17. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH. Cody V; Luft JR; Pangborn W Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506. Kotaka M; Ye H; Alag R; Hu G; Bozdech Z; Preiser PR; Yoon HS; Lescar J Biochemistry; 2008 Jun; 47(22):5951-61. PubMed ID: 18465874 [TBL] [Abstract][Full Text] [Related]
19. Calorimetric studies of ligand binding in R67 dihydrofolate reductase. Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate. Tsukamoto T; Kitazume T; McGuire JJ; Coward JK J Med Chem; 1996 Jan; 39(1):66-72. PubMed ID: 8568828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]